FDA Approved: VEOZAH — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VEOZAH (fezolinetant) submitted by Astellas Pharma US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms Due to Menopause

Drugs mentioned

• VEOZAH (fezolinetant)

Snippet

SUPPL AP for VEOZAH (FEZOLINETANT)